41/120
1.7 / 5 stars
All 120 Win/Lose results shown below
NATR Roast Me summary
NATURES SUNSHINE PRODUCTS INC (NATR). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseNATR / S&P -9.13% / 15.20% |
LoseNATR / S&P 6.77% / 15.00% |
LoseNATR / S&P 36.49% / 50.40% |
| 2026-Q12/3 |
WinNATR / S&P 11.17% / -4.33% |
LoseNATR / S&P 7.26% / 11.30% |
WinNATR / S&P 107.55% / 27.70% |
| 2025-Q42/3 |
WinNATR / S&P 39.05% / 2.65% |
LoseNATR / S&P 5.67% / 9.00% |
WinNATR / S&P 165.00% / 13.40% |
| 2025-Q31/3 |
LoseNATR / S&P 4.94% / 8.12% |
WinNATR / S&P 6.62% / 4.61% |
LoseNATR / S&P -7.95% / 13.45% |
| 2025-Q21/3 |
WinNATR / S&P 17.85% / 10.94% |
LoseNATR / S&P 4.33% / 4.83% |
LoseNATR / S&P -7.50% / 10.63% |
| 2025-Q10/3 |
LoseNATR / S&P -14.39% / -4.27% |
LoseNATR / S&P 2.00% / 4.98% |
LoseNATR / S&P -37.65% / 10.57% |
| 2024-Q41/3 |
WinNATR / S&P 7.64% / 2.41% |
LoseNATR / S&P 2.03% / 5.25% |
LoseNATR / S&P -48.05% / 6.15% |
| 2024-Q31/3 |
LoseNATR / S&P -9.62% / 5.89% |
LoseNATR / S&P 1.36% / 5.89% |
WinNATR / S&P 114.63% / 6.11% |
| 2024-Q21/3 |
LoseNATR / S&P -27.44% / 4.28% |
LoseNATR / S&P 2.14% / 5.38% |
WinNATR / S&P 207.69% / 5.12% |
| 2024-Q13/3 |
WinNATR / S&P 20.13% / 10.56% |
WinNATR / S&P 6.58% / 5.71% |
WinNATR / S&P 400.00% / 5.59% |
| 2023-Q40/3 |
LoseNATR / S&P 4.35% / 11.69% |
LoseNATR / S&P 5.55% / 6.81% |
LoseNATR / S&P NATR unavailable / 7.78% |
| 2023-Q31/3 |
WinNATR / S&P 21.39% / -3.27% |
LoseNATR / S&P 0.47% / 7.52% |
LoseNATR / S&P -24.07% / -5.03% |
| 2023-Q21/3 |
WinNATR / S&P 33.69% / 8.74% |
LoseNATR / S&P -3.33% / 9.50% |
LoseNATR / S&P -66.67% / -8.57% |
| 2023-Q11/3 |
WinNATR / S&P 22.72% / 7.50% |
LoseNATR / S&P -7.10% / 10.77% |
LoseNATR / S&P -84.11% / -15.69% |
| 2022-Q40/3 |
LoseNATR / S&P 0.97% / 7.56% |
LoseNATR / S&P -4.99% / 11.88% |
LoseNATR / S&P -101.41% / -17.99% |
| 2022-Q30/3 |
LoseNATR / S&P -22.77% / -4.88% |
LoseNATR / S&P 2.15% / 13.47% |
LoseNATR / S&P -48.57% / -1.41% |
| 2022-Q20/3 |
LoseNATR / S&P -36.56% / -16.10% |
LoseNATR / S&P 8.21% / 13.71% |
LoseNATR / S&P -32.17% / 11.04% |
| 2022-Q10/3 |
LoseNATR / S&P -9.08% / -4.60% |
LoseNATR / S&P 15.43% / 15.97% |
LoseNATR / S&P -4.46% / 42.23% |
| 2021-Q42/3 |
WinNATR / S&P 26.28% / 11.03% |
WinNATR / S&P 15.29% / 15.00% |
LoseNATR / S&P 32.71% / 96.40% |
| 2021-Q31/3 |
LoseNATR / S&P -15.66% / 0.58% |
WinNATR / S&P 14.06% / 10.77% |
LoseNATR / S&P 26.51% / 69.42% |
| 2021-Q22/3 |
LoseNATR / S&P -12.98% / 8.55% |
WinNATR / S&P 13.75% / 6.58% |
WinNATR / S&P 105.36% / 51.81% |
| 2021-Q13/3 |
WinNATR / S&P 40.97% / 6.17% |
WinNATR / S&P 6.77% / -1.06% |
WinNATR / S&P 173.17% / 7.39% |
| 2020-Q43/3 |
WinNATR / S&P 29.21% / 12.15% |
WinNATR / S&P 6.35% / -3.72% |
WinNATR / S&P 214.71% / -33.42% |
| 2020-Q33/3 |
WinNATR / S&P 28.41% / 8.93% |
WinNATR / S&P 1.97% / -2.04% |
WinNATR / S&P 453.33% / -27.10% |
| 2020-Q21/3 |
LoseNATR / S&P 10.82% / 20.54% |
LoseNATR / S&P -1.29% / -0.46% |
WinNATR / S&P 250.00% / -27.11% |
| 2020-Q12/3 |
WinNATR / S&P -8.96% / -19.60% |
LoseNATR / S&P -0.51% / 3.47% |
WinNATR / S&P 1950.00% / -14.75% |
| 2019-Q40/3 |
LoseNATR / S&P 7.72% / 9.07% |
LoseNATR / S&P -0.71% / 5.36% |
LoseNATR / S&P NATR unavailable / 2.99% |
| 2019-Q30/3 |
LoseNATR / S&P -10.76% / 1.70% |
LoseNATR / S&P 3.42% / 5.02% |
LoseNATR / S&P NATR unavailable / 0.21% |
| 2019-Q20/3 |
LoseNATR / S&P 0.00% / 4.30% |
LoseNATR / S&P 3.37% / 6.64% |
LoseNATR / S&P NATR unavailable / 8.65% |
| 2019-Q11/3 |
WinNATR / S&P 13.99% / 13.65% |
LoseNATR / S&P 6.49% / 8.12% |
LoseNATR / S&P NATR unavailable / 14.29% |
| 2018-Q41/3 |
WinNATR / S&P -6.86% / -13.52% |
LoseNATR / S&P 6.66% / 9.05% |
LoseNATR / S&P NATR unavailable / 18.23% |
| 2018-Q30/3 |
LoseNATR / S&P -6.42% / 7.71% |
LoseNATR / S&P 5.34% / 10.21% |
LoseNATR / S&P NATR unavailable / 19.06% |
| 2018-Q20/3 |
LoseNATR / S&P -15.00% / 3.43% |
LoseNATR / S&P 6.70% / 9.03% |
LoseNATR / S&P NATR unavailable / 14.46% |
| 2018-Q10/3 |
LoseNATR / S&P -4.76% / -0.76% |
LoseNATR / S&P 1.29% / 7.68% |
LoseNATR / S&P -741.67% / 12.46% |
| 2017-Q41/3 |
WinNATR / S&P 13.79% / 6.64% |
LoseNATR / S&P 0.26% / 7.03% |
LoseNATR / S&P -727.27% / 13.82% |
| 2017-Q30/3 |
LoseNATR / S&P -23.40% / 4.48% |
LoseNATR / S&P 0.15% / 5.68% |
LoseNATR / S&P -117.91% / 17.57% |
| 2017-Q21/3 |
WinNATR / S&P 32.50% / 3.09% |
LoseNATR / S&P 0.75% / 4.83% |
LoseNATR / S&P -105.00% / 17.74% |
| 2017-Q11/3 |
LoseNATR / S&P -32.67% / 6.07% |
WinNATR / S&P 5.76% / 3.67% |
LoseNATR / S&P -79.66% / 13.32% |
| 2016-Q41/3 |
LoseNATR / S&P -5.62% / 3.82% |
WinNATR / S&P 5.07% / 2.09% |
LoseNATR / S&P -85.71% / 7.05% |
| 2016-Q33/3 |
WinNATR / S&P 69.21% / 3.85% |
WinNATR / S&P 1.76% / 0.20% |
WinNATR / S&P 109.38% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | NATR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -15.64% | 20.78% |
| Annualized return | -15.64% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | NATR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -18.63% | 83.14% |
| Annualized return | -4.04% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | NATR total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 11.64% | 319.30% |
| Annualized return | 1.11% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |